Why partner with Recordati
Recordati is a global pharmaceutical group with more than 4,300 employees and has a direct presence in all key geographies.
Recordati is a partner of choice due to its unique structure, bringing treatment options across specialty and primary care, consumer healthcare, and rare diseases. We have fully integrated operations across research & development, chemical and finished product manufacturing through to commercialisation and licensing. We are continually growing, with a focus on developing new specialties, new treatments and investing in medical innovations that bring a brighter future to patients across the world.
Partnerships are a core component of Recordati’s successful history. The company has developed a long-standing track record and commitment to partnering and we have the focus to treat each product as if it were our own.
Strong capabilities
& global reach
- Fully integrated company with successful track record in developing, registering, manufacturing and commercialising medicinal products
- Global footprint with direct presence in more than 30 countries and partnerships in remaining markets
Focus
- A “local brilliance” commercial approach to each and every market, ensuring growth opportunities are maximised
- Growth driven by focus on few strategic products that add value to patients, payers and physicians
- We treat each partnered product as if it were our own
Business development
track record
- Creative and flexible deal structures to share value with partners
- Long-lasting strategic partnerships
- More than 35 transactions completed in the last 15 years
Specialty & Primary Care
- Recordati Specialty and Primary Care has significant scope and scale with cost-effective and competitive commercial capabilities in every market in which we operate.
- We are the go-to partner for innovative treatments in our core therapeutic areas as well as for promotionally sensitive established and marketed products across multiple therapy areas.
- We invest and focus on local and regional flagship brands in consumer healthcare, combining digital innovation and clinical advocacy.
Rare Diseases
- Recordati Rare Diseases has a global footprint with direct commercial presence in major markets.
- We are the go-to partner for global, regional and local partnerships for innovative rare disease treatments with a particular focus in our core therapeutic areas.
Our Business Development Strategy
We are looking for in-licensing and acquisition opportunities to strengthen our pipeline and portfolio in the following areas:
Rare Diseases
Innovative products from Clinical Proof of Concept programmes to marketed products, in all therapeutic areas and with a particular focus on:
- Rare Endocrinology
- Rare Metabolism
- Rare Oncology
Specialty & Primary Care
Innovative products from Phase 2b clinical stage to marketed products in:
- Cardio-metabolism
- Urology/Uro-Oncology
- Gastrointestinal
Established and marketed products across any therapeutic area
Consumer Healthcare
Well established and marketed CHC products mainly in categories such as:
- Digestive Health
- Women’s Health & Intimate Care
- Respiratory Health